The dental bone graft substitute market is expected to grow from US$ 533.5 million in 2022 to US$ 1,011.2 million by 2030; it is anticipated to record a CAGR of 8.3% from 2022 to 2030.

A dental bone graft is necessary when bone loss has occurred in the jaw. This procedure is commonly performed before dental implant placement or when bone loss negatively affects neighboring teeth. A dental bone graft adds volume and density to jaw in areas where bone loss has occurred. The bone graft material may be taken from own body (autogenous), or it may be purchased from a human tissue bank (allograft) or an animal tissue bank (xenograft). In some instances, the bone graft material may be synthetic (alloplast). The dental bone graft substitute market size is growing rapidly due to the increasing number of dental diseases and growing instances of dental procedures due to cosmetic appearance. The increasing prevalence of dental diseases and the introduction of supportive government initiatives regarding dental bone graft substitutes are among the most enduring growth drivers of the dental bone graft substitute market.

Technologically Advancements Creates Opportunity for the Growth of the Dental Bone Graft Substitute Market

Technological developments make it easier for dentists to do their job quickly, safely, and comfortably. Technologically advanced instruments make dental hygiene appointments much more pleasant for patients than they used to be. As a result, patients become compliant and willingly schedule treatment and recall visits. Restorative dentistry benefits oral health, specifically facial appearance, effective teeth, and oral care. Dentists can insert implants through minimally invasive surgeries using new dental implantation techniques and advanced navigation and monitoring technologies. Further, augmented reality (AR) technology is more prevalent in reconstructive and aesthetic procedures in dental practices, as it can simulate a realistic digital preview of how patients can look post treatment. Also, the increasing adoption of synthetic bone substitutes is likely to favor the growth of the US dental bone graft substitute market. For example, in 2020, Orthopediatrics Corp., a company focused solely on pediatric orthopedics, launched QuickPack, an all-synthetic replacement containing a high-viscosity calcium phosphate cement that mimics the mineral phase of natural bone. In July 2020, Spine Wave Inc. announced the successful launch of tempest allograft bone matrix. The tempest allograft bone matrix comprises cancellous and partially demineralized cortical bone. Such technological developments in dental bone graft substitute market are expected to provide opportunities for the dental bone graft substitute market growth in the coming years.

Oral diseases are highly preventable. However, these diseases are a major health issue in many countries and affect people throughout their lifetime. Several common dental issues include periodontal diseases, dental caries (tooth decay), and tooth loss. The increasing prevalence of dental diseases is causing the need for teeth replacement, dental crowns, copings, and dental bridges. As per the World Health Organization (WHO) Global Oral Health Status Report (2022), about 3 out of 4 people are affected due to oral diseases globally, of which ~3.5 billion people live in middle-income countries. Additionally, ~2 billion people globally suffer from dental caries in permanent teeth, and about 514 million children suffer from primary teeth caries. The growing prevalence rate of dental problems such as crooked teeth, overbites, spaces between teeth, and overcrowding is creating the demand for dental bone graft substitutes to treat such problems. For instance, as per the Centers for Disease Control and Prevention (CDC), in the US, about 47.2% of adults above 30 years of age have some periodontal disease, and which increases with age; and about 70.1% of adults over the age of 65 years suffered from periodontal disease in 2020. This surging number of people suffering from dental diseases is fueling the demand of dental bone graft substitutes for easy and rapid treatment. Therefore, the increase in the prevalence of oral diseases worldwide is fueling the growth of the dental bone graft substitute market.

Based on geography, the dental bone graft substitute market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global dental bone graft substitute market in 2022 owing to the increasing technological advancements, rising number of dental diseases and disorders, presence of geriatric population, and a significantly high number of key market players involved in new and existing product developments. However, Asia Pacific is predicted to register the highest CAGR from 2022 to 2030. The US held North America's largest share of the dental bone graft substitute market in 2022. US market players are adopting organic and inorganic strategies for dental bone graft substitute market development. For instance, in September 2021, Straumann Group announced a strategic partnership with Aspen Dental Management, Inc. (ADMI) to provide dental implant solutions, abutments, and CAD/CAM options to more than 1,000 ADMI and affiliated workplaces throughout 45 US states. As a part of the agreement, Straumann Group will supply Aspen Dental-supported and ClearChoice-supported independent practices with a wide variety of dental implants and CAD/CAM solutions. Furthermore, in January 2021, Nobel Biocare invited dental practitioners to join the Mucointegration era by introducing the Xeal and TiUltra surfaces in the US. These novel surfaces are used on implants and abutments to improve tissue integration at every level. Thus, the factors mentioned above support the market growth. Substantial increase in oral condition, implementation of strategic policies by market players, and higher awareness about the utilization of dental consumables represent the considerable market share and growth of Canada's dental consumables market. According to a study published by Smile Montreal Dentistry in 2020, around 98% of Canadians encounter some or the other kind of oral condition once in their lifetime. Moreover, according to a study published by the Canadian Dental Association, around 7 out of 10 Canadians suffer from gum disease. Thus, the growing number of dental problems in North America is fueling the growth of the dental bone graft substitute market.

ClinicalTrails.com, Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Health Services (NHS) are a few key primary and secondary sources referred to while preparing the report on the dental bone graft substitute market.